Comparison of Treatment Response in Idiopathic and Connective Tissue Disease–associated Pulmonary Arterial Hypertension
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Treatment Response in Idiopathic and Connective Tissue Disease–associated Pulmonary Arterial Hypertension
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 192, Issue 9, Pages 1111-1117
Publisher
American Thoracic Society
Online
2015-08-21
DOI
10.1164/rccm.201507-1456oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Data Sharing, Year 1 — Access to Data from Industry-Sponsored Clinical Trials
- (2014) Brian L. Strom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
- (2013) Dinesh Khanna et al. ARTHRITIS AND RHEUMATISM
- Survival and Prognostic Factors in Systemic Sclerosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
- (2013) Guillaume Lefèvre et al. ARTHRITIS AND RHEUMATISM
- Survival in Systemic Sclerosis With Pulmonary Arterial Hypertension Has Not Improved in the Modern Era
- (2013) Melvyn Rubenfire et al. CHEST
- Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)
- (2013) Victor F. Tapson et al. CHEST
- Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension
- (2013) Zhi-Cheng Jing et al. CIRCULATION
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
- (2013) Tomás Pulido et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does Raising Type 1 Error Rate Improve Power to Detect Interactions in Linear Regression Models? A Simulation Study
- (2013) Casey P. Durand PLoS One
- Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials
- (2013) Masataka Kuwana et al. BMJ Open
- Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)
- (2012) Victor F. Tapson et al. CHEST
- Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials
- (2012) Nicole B. Gabler et al. CIRCULATION
- The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH
- (2011) Philip J Clements et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension
- (2011) Julio Sandoval et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL
- (2010) Lorinda Chung et al. CHEST
- Predicting Survival in Pulmonary Arterial Hypertension
- (2010) Raymond L. Benza et al. CIRCULATION
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
- (2010) Marc Humbert et al. CIRCULATION
- Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease
- (2010) J Gerry Coghlan et al. CURRENT OPINION IN PULMONARY MEDICINE
- Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
- (2010) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pulmonary Hypertension in Systemic Sclerosis
- (2010) Soumya Chatterjee SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tadalafil Therapy for Pulmonary Arterial Hypertension
- (2009) Nazzareno Galiè et al. CIRCULATION
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
- (2009) et al. EUROPEAN HEART JOURNAL
- Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
- (2009) M. J. Overbeek et al. EUROPEAN RESPIRATORY JOURNAL
- Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma
- (2009) M. C. GARIN et al. JOURNAL OF RHEUMATOLOGY
- Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis
- (2009) Y. SCHOINDRE et al. JOURNAL OF RHEUMATOLOGY
- Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
- (2008) Robin Condliffe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- (2008) Nazzareno Galiè et al. CIRCULATION
- Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
- (2007) J Avouac et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started